The goal of this study was to explore the relation between oxygen kinetics during constant work load submaximal cardiopulmonary exercise test (CPET) and disease severity in adult subjects with cystic fibrosis.
METHODS:
Fourteen adult subjects with cystic fibrosis (CF; 8 males, 22 ± 4 y old) and a mean Schwachman score of 73 ± 11 and 10 healthy individuals (5 males, 29 ± 4 y old) underwent pulmonary function tests at rest, maximal and constant work load submaximal CPET on a cycloergometer. Breath-by-breath analysis was used for measuring oxygen kinetic parameters and the time constant (tau), expressing phase 2 of submaximal CPET.
RESULTS:
Subjects with CF had a significantly prolonged tau compared with healthy subjects (42.3 ± 21.5 vs 29.3 ± 6.4, s, P < .05). The tau during phase 2 was inversely correlated with FEV1(% pred) (r = −0.77, P = .001), breathing reserve (r = −0.74, P = .003), V̇O2peak (r = −0.53, P = .049), V̇O2/t slope (r = −0.58, P = .03), and Schwachman score (r = −0.80, P = .001). In a multivariate regression model including all the above variables, the Schwachman score (β = −0.697, P = .002) emerged as independent predictor of tau (R2 = 0.719, P = .001).
CONCLUSIONS:
We conclude that adult subjects with CF present significant prolonged oxygen kinetics during constant work load submaximal exercise in relation to disease severity. Thus, submaximal exercise should be considered the preferable CPET choice in adult patients with severe CF.
RohlfsEM, ZhouZ, HeimRA, NaganN, RosenblumLS, FlynnK, et al. Cystic fibrosis carrier testing in an ethnically diverse US population. Clin Chem, 2011; 57(6):841–848.
2.
CantN, PollockN, FordRC. CFTR structure and cystic fibrosis. Int J Biochem Cell Biol, 2014; 52:15–25.
3.
HewerSC, TyrrellJ. Cystic fibrosis and the transition to adult health services. Arch Dis Child, 2008; 93(10):817–821.
4.
SawickiGS, DillEJ, AsherD, SellersDE, RobinsonWM. Advance care planning in adults with cystic fibrosis. J Palliat Med, 2008; 11(8):1135–1141.
5.
SimmondsNJ, MacneillSJ, CullinanP, HodsonME. Cystic fibrosis and survival to 40 years: a case-control study. Eur Respir J, 2010; 36(6):1277–1283.
6.
MacKenzieT, GiffordAH, SabadosaKA, QuintonHB, KnappEA, GossCH, et al. Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the cystic fibrosis foundation patient registry. Ann Int Med, 2014; 161(4):233–241.
7.
CourtneyJM, BradleyJ, McCaughanJ, O'ConnorTM, ShorttC, BredinCP, et al. Predictors of mortality in adults with cystic fibrosis. Pediatr Pulmonol, 2007; 42(6):525–532.
8.
UrquhartDS. Exercise testing in cystic fibrosis: why (and how)?. J R Soc Med, 104Suppl 1:S6–14, 2011.
9.
ShwachmanH, KulczyckiLL. Long-term study of one hundred five patients with cystic fibrosis; studies made over a five- to fourteen-year period. J Dis Child, 1958; 96(1):6–15.
10.
PouliouE, NanasS, PapamichalopoulosA, KyprianouT, PerpatiG, MavrouI, Roussos. Prolonged oxygen kinetics during early recovery from maximal exercise in adult patients with cystic fibrosis. Chest, 2001; 119(4):1073–1078.
11.
PastreJ, PrevotatA, TardifC, LangloisC, DuhamelA, WallaertB. Determinants of exercise capacity in cystic fibrosis patients with mild-to-moderate lung disease. BMC Pulm Med, 2014; 14:74.
12.
AlmajedA, LandsLC. The evolution of exercise capacity and its limiting factors in cystic fibrosis. Paediatr Respir Rev, 2012; 13(4):195–199.
13.
HebestreitH, HebestreitA, TrusenA, HughsonRL. Oxygen uptake kinetics are slowed in cystic fibrosis. Med Sci Sports Exerc, 2005; 37(1):10–17.
14.
MillerMR, HankinsonJ, BrusascoV, BurgosF, CasaburiR, CoatesA, et al. Standardisation of spirometry. Eur Respir J, 2005; 26(2):319–338.
15.
PapazachouO, Anastasiou-NanaM, SakellariouD, TassiouA, DimopoulosS, VenetsanakosJ, et al. Pulmonary function at peak exercise in patients with chronic heart failure. Int J Cardiol, 2007; 118(1):28–35.
16.
PerpatiG, NanasS, PouliouE, DionyssopoulouV, StefanatouE, ArmeniakouE, et al. Resting respiratory variables and exercise capacity in adult patients with cystic fibrosis. Respir Med, 2010; 104(10):1444–1449.
17.
HansenJE, SueDY, WassermanK. Predicted values for clinical exercise testing. Am J Respir Dis, 129(2 Pt 2):S49–55, 1984.
18.
BeaverWL, WassermanK, WhippBJ. A new method for detecting anaerobic threshold by gas exchange. J Appl Physiol, 1986; 60(6):2020–2027.
19.
NanasS, NanasJ, KassiotisC, AlexopoulosG, SamakovliA, KanakakisJ, et al. Respiratory muscles performance is related to oxygen kinetics during maximal exercise and early recovery in patients with congestive heart failure. Circulation, 1999; 100(5):503–508.
20.
RoditisP, DimopoulosS, SakellariouD, SarafoglouS, KaldaraE, VenetsanakosJ, et al. The effects of exercise training on the kinetics of oxygen uptake in patients with chronic heart failure. Eur J Cardiovasc Prev Rehab, 2007; 14(2):304–311.
21.
VasileiadisI, RoditisP, DimopoulosS, LadisV, PangalisG, AessoposA, et al. Impaired oxygen kinetics in beta-thalassaemia major patients. Acta Physiol, 2009; 196(3):357–363.
22.
LamarraN, WhippBJ, WardSA, WassermanK. Effect of interbreath fluctuations on characterizing exercise gas exchange kinetics. J Appl Physiol, 1987; 62(5):2003–2012.
23.
WhippBJ, RossiterHB, WardSA. Exertional oxygen uptake kinetics: a stamen of stamina?. Biochem Soc Trans, 2002; 30(2):237–247.
24.
WhippBJ, WardSA, LamarraN, DavisJA, WassermanK. Parameters of ventilatory and gas exchange dynamics during exercise. J Appl Physiol, 1982; 52(6):1506–1513.
25.
SomfayA, PórszászJ, LeeSM, CasaburiR. Effect of hyperoxia on gas exchange and lactate kinetics following exercise onset in nonhypoxemic COPD patients. Chest, 2002; 121(2):393–400.
26.
ChiappaGR, Borghi-SilvaA, FerreiraLF, CarrascosaC, OliveiraCC, MaiaJ, et al. Kinetics of muscle deoxygenation are accelerated at the onset of heavy-intensity exercise in patients with COPD: relationship to central cardiovascular dynamics. J Appl Physiol, 2008; 104(5):1341–1350.
27.
MettauerB, ZhaoQM, EpaillyE, CharlouxA, LampertE, Heitz-NaegelenB, et al. VO(2) kinetics reveal a central limitation at the onset of subthreshold exercise in heart transplant recipients. J Appl Physiol, 2000; 88(4):1228–1238.
28.
FukuokaY, GrassiB, ContiM, GuiducciD, SuttiM, MarconiC, et al. Early effects of exercise training on on- and off-kinetics in 50-year-old subjects. Pflugers Arch Eur J Physiol, 2002:443(5–6):690–697.
29.
GrassiB. Skeletal muscle VO2 on-kinetics: set by O2 delivery or by O2 utilization? New insights into an old issue. Med Sci Sports Exercise, 2000; 32(1):108–116.
30.
ManikaK, PitsiouGG, BoutouAK, TsaoussisV, ChavouzisN, AntoniouM, et al. The impact of pulmonary arterial pressure on exercise capacity in mild-to-moderate cystic fibrosis: a case control study. Pulm Med, 2012;252345, 2012.
31.
ShapiroBL. Evidence for a mitochondrial lesion in cystic fibrosis. Life Sci, 1989; 44(19):1327–1334.
ShapiroBL, FeigalRJ, LamLF. Mitrochondrial NADH dehydrogenase in cystic fibrosis. Proc Natl Acad Sci USA, 1979; 76(6):2979–2983.
34.
de MeerK, JenesonJA, GulmansVA, van der LaagJ, BergerR. Efficiency of oxidative work performance of skeletal muscle in patients with cystic fibrosis. Thorax, 1995; 50(9):980–983.
